Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Dupilumab for Severe Eosinophilic Chronic Sinusitis
Recruiting1 awardPhase 2
Tampa, Florida
This trial will test how well dupilumab works in patients with severe eosinophilic chronic rhinosinusitis who haven't responded to other treatments and have significant disease involving more than two sinuses bilaterally.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.